- Home
- STOK vs AHG Comparison
STOK vs AHG Comparison
Compare STOK & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- AHG
- Stock Information
- Founded
- STOK 2014
- AHG 2013
- Country
- STOK United States
- AHG China
- Employees
- STOK N/A
- AHG N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- AHG Business Services
- Sector
- STOK Health Care
- AHG Consumer Discretionary
- Exchange
- STOK Nasdaq
- AHG Nasdaq
- Market Cap
- STOK 638.8M
- AHG 765.9M
- IPO Year
- STOK 2019
- AHG N/A
- Fundamental
- Price
- STOK $12.03
- AHG $1.57
- Analyst Decision
- STOK Strong Buy
- AHG
- Analyst Count
- STOK 5
- AHG 0
- Target Price
- STOK $24.50
- AHG N/A
- AVG Volume (30 Days)
- STOK 541.2K
- AHG 13.0K
- Earning Date
- STOK 08-06-2025
- AHG 07-22-2025
- Dividend Yield
- STOK N/A
- AHG N/A
- EPS Growth
- STOK N/A
- AHG N/A
- EPS
- STOK 0.88
- AHG N/A
- Revenue
- STOK $190,908,000.00
- AHG $8,454,946.00
- Revenue This Year
- STOK $378.84
- AHG N/A
- Revenue Next Year
- STOK N/A
- AHG N/A
- P/E Ratio
- STOK $13.80
- AHG N/A
- Revenue Growth
- STOK 2333.81
- AHG 281.19
- 52 Week Low
- STOK $5.35
- AHG $0.74
- 52 Week High
- STOK $16.15
- AHG $2.35
- Technical
- Relative Strength Index (RSI)
- STOK 67.00
- AHG 58.73
- Support Level
- STOK $11.19
- AHG $1.07
- Resistance Level
- STOK $12.00
- AHG $1.23
- Average True Range (ATR)
- STOK 0.54
- AHG 0.11
- MACD
- STOK -0.04
- AHG 0.02
- Stochastic Oscillator
- STOK 75.30
- AHG 67.69
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
About AHG Akso Health Group ADS
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.